WIXLIB

Nutrition & HealthAnup KothariPresident Nutrition & Health divisionBASF Capital Markets Day, March 26, 20211BASF Capital Markets Day, March 26, 2021 I Nutrition & Health

Cautionary note regardingforward-looking statementsThis presentation contains forward-looking statements. These statements are based on currentestimates and projections of the Board of Executive Directors and currently available information.Forward-looking statements are not guarantees of the future developments and results outlinedtherein. These are dependent on a number of factors; they involve various risks and uncertainties; andthey are based on assumptions that may not prove to be accurate. Such risk factors include thosediscussed in Opportunities and Risks on pages 158 to 166 of the BASF Report 2020. BASF does notassume any obligation to update the forward-looking statements contained in this presentation aboveand beyond the legal requirements.2BASF Capital Markets Day, March 26, 2021 I Nutrition & Health

Fundamentals: Trends - Division - Sales split - Financials - Asset footprint - Portfolio I Growth leversNutrition & Health targets consumer-driven ingredient marketsworth 80 billion1 with robust growth rates and low cyclicality 7bn3-4%2 40bn nutrition 8bn6 %2PharmaHigher demand for natural ingredientsEco-friendliness and sustainability becoming the decisive purchasing factorsHealth benefits and convenience of growing relevance3BASF Capital Markets Day, March 26, 2021 I Nutrition & Health1 Source:BASF primary and secondary market research 2 Expected market CAGR 2019–2024 4bn3 %2Enzymes

Fundamentals: Trends - Division - Sales split - Financials - Asset footprint - Portfolio I Growth leversNutrition & Health businesses hold or strive for leading positionsamong suppliers in their market segments21%1Aromaingredients25%1Animalnutrition Cost leadership in citraland derivatives Pioneer and innovatorin feed enzymes Strong volume growthafter startup of aromaingredients complex inKuantan, Malaysia Enabler for reduction ofantibiotics 60 products in the scentranges mint, citrus, rose,lavender, muguet425%1Humannutrition28%1PharmasolutionsBASF Capital Markets Day, March 26, 2021 I Nutrition & Health2 AdditionalEnzymes2 Among leading players inspecialty healthingredients Innovative excipientsplayer for variousapplications BASF strives for aleading position in theglobal enzymes market Solution provider indesserts and artisanalbakery Strong player inibuprofen andomega-3 New Global BusinessUnit acts as central hub Cost leadership invitamin A, strong position Pioneer in vitamin A food Enables production ofin vitamin Efortificationbiologic drugs1 Percentage1%1of Nutrition & Health division sales 2020sales with enzymes are generated in animal nutrition and the Care Chemicals division Innovation programensures a continuousstream of new products

Fundamentals: Trends - Division - Sales split - Financials - Asset footprint - Portfolio I Growth leversServing attractive end consumer markets in all regionsSales by direct customer industry 2020Sales by region1 2020South America,Africa, Middle East10%North America18%Others19%Europe37% 2,030 millionHealth27%Asia Pacific35%5BASF Capital Markets Day, March 26, 2021 I Nutrition & Health1 Bylocation of customeringredients business is included in the customer industries nutrition and others2 Aroma 2,030 millionNutrition254%

Fundamentals: Trends - Division - Sales split - Financials - Asset footprint - Portfolio I Growth leversNutrition & Health operates a profitable and growing businessSalesbillion EBITDA bsimargin (%)CAGREBITDA bsi5% Low cyclicality of relevant markets:330%2.0Ø 21% p.a.15%1.00.0201520161201722201820192BASF Capital Markets Day, March 26, 2021 I Nutrition & Health2020 3x less cyclical than the chemical industry 10x less cyclical than the automotive industry From Q4 2017 to Q4 2018, sales growth wasimpacted by force majeure for key product lines0%2016: Peak in vitamin prices2017/2018: Force majeure on citral and isoprenol based aroma ingredients, vitamin A, E and severalcarotenoids, with a significant sales reduction in aroma ingredients, animal and human nutrition3 Compared with actual market growth16 Continuous and resilient earnings contributor withhealthy growth potential

Fundamentals: Trends - Division - Sales split - Financials - Asset footprint - Portfolio I Growth leversNutrition & Health’s global asset footprintEMEA7 Production sites6 Research & development hubs1 Application and technicalservice locationNorth & South America3 Production sites1 Research & development hub2 Application and technicalservice locations7BASF Capital Markets Day, March 26, 2021 I Nutrition & HealthAsia Pacific7 Production sites2 Research & development hubs2 Application and technicalservice locations

Fundamentals: Trends - Division - Sales split - Financials - Asset footprint - Portfolio I Growth leversContinual investment and improvements to global assets to ensurecustomer and market proximityEuropeGlobal headquarters animal nutrition,aroma ingredients and enzymes2021North & South AmericaGlobal headquarterspharma solutionsVitamin A capacityexpansionin Ludwigshafen, Germany2020Improvement ofibuprofen productionin Bishop, Texas2021Capacity expansionenzyme plantin Ludwigshafen, Germany8BASF Capital Markets Day, March 26, 2021 I Nutrition & HealthAsia PacificGlobal headquartershuman nutrition2017–2018New integrated aromaingredients complexin Kuantan, Malaysia

Fundamentals I Growth levers: Sustainability - Innovation - Digitalization - Asia Pacific - CollaborationOur ambition is to innovate sustainably, invest world-classand grow Asia PacificCollaborationWe enablesolutions toreduce CO2emissions and tofight malnutritionWe delivertargetedinnovations forour customersWe strengthenour position as adigital solutionprovider to ourtarget industriesWe meet newconsumerdemands in ourlargest growthmarketWe support ourcustomers withdifferentiatingsolutionsBASF Capital Markets Day, March 26, 2021 I Nutrition & Health

Fundamentals I Growth levers: Sustainability - Innovation - Digitalization - Asia Pacific - CollaborationWe strive for an effective reduction of CO2 emissions in cooperationwith our customers and partnersSustainablepalm oilPharma oleochemicalscertified accordingto RSPO1 in 2019 Up to 36% lower CO2 emissions forkey raw material certified palm kerneloil,3 plus positive impact on biodiversityand social aspects 10% reduction of Product CarbonFootprint of oleo excipients41 RoundtableRenewablefeedstockBiomass balanceproduct offerings savefossil resourcesBASF Capital Markets Day, March 26, 2021 I Nutrition & HealthPilot more sustainableproduct offerings withrenewable energy Up to 20% lower CO2 product Up to 20% lower CO2 emissionfor selected pilot productsthrough renewable energy credits Scalable, drop-in solution and Certification and pilotsstarting 2021emissions throughrenewable feedstockcertified5identical performanceon Sustainable Palm Oil; 2 For selected pilot products; 3 Source: Consultant 2.0, www.LCA-net.com/club/palm-oil/; 4 Due to varying content of palm kernel oilin our pharma oleochemicals, the actual carbon footprint varies by product and can be calculated (incurring additional costs) on demand; 5 REDcert-EU and ISCC-EU10Renewableenergy2

Fundamentals I Growth levers: Sustainability - Innovation - Digitalization - Asia Pacific - CollaborationWe will continue to help fight malnutrition worldwideCall for actionImpact Reduce vitamin A deficiency in developing countries Improve eye health, immune system, child and maternal health Fortification of staple foods to fight nutrient deficiencies in all ages Active in more than 42 countries Served 750 million people at risk of vitamin A deficiency since 2003 Target to serve 3 billion people at risk of vitamin A deficiency by 2050BASF partners11BASF Capital Markets Day, March 26, 2021 I Nutrition & Health

Fundamentals I Growth levers: Sustainability - Innovation - Digitalization - Asia Pacific - CollaborationCreating value in aroma ingredients through smart acquisitionsdelivering targeted innovations for our customers Strong R&D pipeline linkedto customer projects Established customerrelationships with keyflavor and fragrance players Fermentation scale-upexpertiseAcquisition ofIsobionicsProductpipeline 500 10% enceneNootkatoneSantalol (Isobionics )Alpha-BisaboleneGermacrene DAlpha-BisabololMore to comeStrengthening our position in natural aroma ingredients12Fermentation-basedaroma ingredientsmarket to grow byBASF Capital Markets Day, March 26, 2021 I Nutrition & Health1Expected market CAGR 2018–2030 2 Source: BASF primary and secondary market research

Fundamentals I Growth levers: Sustainability - Innovation - Digitalization - Asia Pacific - CollaborationVirtual assistant ZoomLabTM strengthens our leading positionas a digital solution provider for the pharma industry ZoomLabTM helps our customers to save timeand resources in their development pipelinewithout having to share proprietary information Targets all formulators at generic and innovatordrug companies worldwide, with focus onemerging markets3–6 monthsdevelopmenttime saved Disruption of traditional research business modelin collaboration with leading industry partners Accelerated expansion of customer base, buildingnew business opportunities with digital services 90countries13 500completedprojectsBASF Capital Markets Day, March 26, 2021 I Nutrition & Health 800activeusers

Fundamentals I Growth levers: Sustainability - Innovation - Digitalization - Asia Pacific - CollaborationNext-generation farming enabled by recently acquired Cloudfarmspresents new opportunities for livestock producersFirst cloud-based, multi-sitedpig production management systemReal-time data registration with a mobileapp, allowing faster decisions andbetter planning for livestock producersEnabling a closer connection with thevalue chainOur mission: shape the digitalecosystem, improving traceability,animal welfareand sustainability14BASF Capital Markets Day, March 26, 2021 I Nutrition & Health

Fundamentals I Growth levers: Sustainability - Innovation - Digitalization - Asia Pacific - CollaborationAsia Pacific holds strong growth opportunities for Nutrition & Health Asia Pacific is the largest food and pharma market todayFood and pharma market1Regional split, value share 2020–2025Asia Pacific2025: 48%South America5%North America21% Nutrition & Health with double-digit growth in AsiaPacific in 2019 and 2020 High growth potential due to large population andincreasing living standards Health and wellness are driven by calorie-rich dietsAsia Pacific2020: 45% Human nutrition business unit moved headquarters fromGermany to Singapore in 2018 Strengthened market and customer understandingEurope29% Better access to local talent Build-up of technical capacities and capabilities15BASF Capital Markets Day, March 26, 2021 I Nutrition & Health1 Source:BASF primary and secondary market research

Fundamentals I Growth levers: Sustainability - Innovation - Digitalization - Asia Pacific - CollaborationWe help our customers to optimize cost and differentiate themselvesin the biopharma marketSuccess story – excipient Kolliphor P 188 Bio1Sales, indexed 1 61%billionmarket2Global biopharma ingredients marketto grow by 10% p.a.1 Broad pharmaceuticalformulations expertise Global presence to innovatefor local needs20142015Collaborationformalized with162016201720182019Growth to 30 customersBASF Capital Markets Day, March 26, 2021 I Nutrition & Health2020Growth to 50 customers1 Estimated Leading regulatory capabilities Leveraging Verbund integrationmarket growth: CAGR 2019–2029; 2 Source: BASF primary and secondary market research